â– LECTURE OVERVIEW: Acute Rheumatic Fever (ARF) is an autoimmune, post-infectious inflammatory sequela triggered selectively by Streptococcus pyogenes (Group A Beta-Hemolytic Streptococcus, GAS) pharyngitis.
â– IMMUNOPATHOGENIC DETAILS:
1. M Protein (Antiphagocytic): S. pyogenes expresses M Protein, a coiled-coil alpha-helical protein that projects from the cell membrane, preventing phagocytosis by binding fibrinogen and inhibiting complement.
2. Epitopic Mimicry: The structural epitopes of M Protein are highly homologous to human coiled-coil proteins, specifically alpha-myosin and sarcolemma proteins in cardiac tissue, as well as joint and brain antigens.
3. Trans-Activation of B-Cells: The host immune system mounts a vigorous humoral response against the streptococcal M antigen, generating Anti-M antibodies.
4. Autoimmune Damage: These cross-react with cardiac self-antigens, activating the classical complement cascade and recruiting macrophages to healthy cardiac tissue, causing myocarditis, endocarditis, and pericarditis (pancarditis).
â– GENETIC LINKED CARRIERS & HERITABILITY ANALYSIS:
Molecular mapping has located corresponding loci aberrations. Pedigree analysis demonstrates variable expressivity, incomplete penetrance, and parent-of-origin genomic imprinting impacts.
â– CLINICAL CASE SUMMARY:
A 45-year-old patient presented with acute clinical deterioration. Aggressive initial stabilization, molecular monitoring, and specialized pathology screening confirmed the classic disease hallmarks.
[HY-BOARD-1038]
🌟 Dynamic Clinical Key:
ARF develops 2-4 weeks after untreated streptococcal pharyngitis (never skin infections/impetigo). Diagnosed via the Jones criteria (joints arthritis, heart carditis, subcutaneous nodules, erythema marginatum, Sydenham chorea). Early treatment of GAS with Penicillin completely prevents ARF. Provide formal genetic counseling for parents requesting family-planning assessment when carriers are present. Clinical vigilance during early presentation prevents progression along the severe outcome pathway.